(Q36764012)

16 August 2017

1 reference

title

Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer (English)

1 reference

16 August 2017

1 reference

Elwyn Cabebe

1

1 reference

PubMed ID

17371195

16 August 2017

George A Fisher

series ordinal

2

1 reference

PubMed ID

17371195

16 August 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

Expert Opinion on Investigational Drugs

16 August 2017

1 reference

16 August 2017

16

1 reference

16 August 2017

467-476

1 reference

16 August 2017

4

1 reference

16 August 2017

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

Regulation of angiogenesis by hypoxia: role of the HIF system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

VEGF-receptor signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

ZD6474--a novel inhibitor of VEGFR and EGFR tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

The Raf kinase inhibitor BAY 43-9006 reduces cellular uptake of platinum compounds and cytotoxicity in human colorectal carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.467

10.1517/13543784.16.4.467

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17371195